ACA
ROIVW

Arena Capital Advisors’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Arena Capital Advisors’s Portfolio ROIVW Stock Details ROIVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-59,775
Closed -$87.3K – 84
2023
Q1 		$87.3K Hold
59,775
– – 0.12% 41
2022
Q4 		$116K Hold
59,775
– – 0.06% 73
2022
Q3 		$23K Hold
59,775
– – 0.01% 143
2022
Q2 		$36K Hold
59,775
– – 0.01% 167
2022
Q1 		$53K Sell
59,775
-90,225
-60% -$115K 0.01% 204
2021
Q4 		$307K Buy
+150,000
New +$229K 0.03% 213

Other funds holding ROIVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Arena Capital Advisors's ROIVW Position: Q2 2023 in Review

Arena Capital Advisors sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q2 2023, closing a stake of 59,775 shares — an estimated $87.3K sold.

Arena Capital Advisors first reported a position in ROIVW in Q4 2021 and held it in 6 quarters. The position peaked at $307K in Q4 2021. 26 funds tracked by Wall St. Rank hold ROIVW as of Q2 2023.

  • Arena Capital Advisors reported no remaining Roivant Sciences Ltd. Warrant position as of Q2 2023 after selling out during the quarter.
  • Arena Capital Advisors sold 59,775 Roivant Sciences Ltd. Warrant shares in Q2 2023, an estimated $87.3K.
  • Arena Capital Advisors first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 6 quarters.
  • Arena Capital Advisors's Roivant Sciences Ltd. Warrant position peaked at $307K in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q2 2023.

Based on Arena Capital Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.